<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immunosuppressive therapy related secondary <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematologic malignancy</z:e> is well reported </plain></SENT>
<SENT sid="1" pm="."><plain>A 52 years lady with established <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> developed reactive <z:hpo ids='HP_0011034'>amyloidosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This was initially treated with <z:chebi fb="0" ids="23359">colchicine</z:chebi> and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and later with <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Ten months after stopping <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> she developed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> deficient <z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> was refractory to <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> supplements and a repeat bone marrow confirmed <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (FABI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Within three weeks of this diagnosis she evolved into <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> and expired due to refractory <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and uncontrolled <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>This case stresses the need for long term follow up of RA patients treated with <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> </plain></SENT>
</text></document>